EntryPoint Capital’s Arvinas ARVN Stock Holding History

EntryPoint Capital’s Portfolio ARVN Stock Details ARVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-21,458	Closed	-$529K	–	712
2024 Q3	$529K	Buy	21,458 +17,009	+382%	+$444K	0.3%	37
2024 Q2	$118K	Buy	+4,449	New	+$142K	0.17%	238

Other funds holding ARVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

EntryPoint Capital's ARVN Position: Q4 2024 in Review

EntryPoint Capital sold out of Arvinas (ARVN) in Q4 2024, closing a stake of 21,458 shares — an estimated $529K sold.

EntryPoint Capital first reported a position in ARVN in Q2 2024 and held it in 2 quarters. The position peaked at $529K in Q3 2024. 198 funds tracked by Wall St. Rank hold ARVN as of Q4 2024.

EntryPoint Capital reported no remaining Arvinas position as of Q4 2024 after selling out during the quarter.
EntryPoint Capital sold 21,458 Arvinas shares in Q4 2024, an estimated $529K.
EntryPoint Capital first reported a position in Arvinas in Q2 2024 and held it in 2 quarters.
EntryPoint Capital's Arvinas position peaked at $529K in Q3 2024.
198 funds tracked by Wall St. Rank held Arvinas as of Q4 2024.

Based on EntryPoint Capital's 13F filing for Q4 2024, filed 11 Feb 2025.